Expression of 5-lipoxygenase by human colorectal carcinoma Caco-2 cells during butyrate-induced cell differentiation

被引:35
作者
Wächtershäuser, A
Steinhilber, D
Loitsch, SM
Stein, J
机构
[1] Univ Frankfurt, Med Klin 2, Dept Med 2, D-60590 Frankfurt, Germany
[2] Univ Frankfurt, Inst Pharmaceut Chem, D-60590 Frankfurt, Germany
关键词
D O I
10.1006/bbrc.2000.2213
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Butyrate, a short-chain fatty acid, modulates proliferation and differentiation of normal and neoplastic colonocytes. We examined the expression of B-Lipoxygenase (5-LO) and its metabolites in human colorectal carcinoma (Caco-2) cells, exposed to differentiation-inducing doses-of butyrate. Treatment with butyrate significantly increased 5-lipoxygenase mRNA and protein in comparison to nontreated cells. Cyclooxygenases (COX)-1 and COX-2 mRNA were not significantly influenced by the treatment. However, 5-LO activity, low in nontreated cells, increased only minimally after butyrate, and its metabolic product (5-HETE) was detectable neither in control nor in treated cells. In contrast, 15-HETE (a product of 15-LO, which is also upregulated by butyrate) rose significantly, We conclude that, although being overexpressed by butyrate on mRNA and protein level, 5-LO remains inactive in differentiating Caco-2 cells. This is likely to be due either to some associated actions of butyrate, or to 5-LO-inhibition by 15-HETE, concomitantly induced by butyrate treatment. (C) 2000 Academic Press.
引用
收藏
页码:778 / 783
页数:6
相关论文
共 32 条
[21]   TYPE-BETA TRANSFORMING GROWTH-FACTOR IS THE PRIMARY DIFFERENTIATION-INDUCING SERUM FACTOR FOR NORMAL HUMAN BRONCHIAL EPITHELIAL-CELLS [J].
MASUI, T ;
WAKEFIELD, LM ;
LECHNER, JF ;
LAVECK, MA ;
SPORN, MB ;
HARRIS, CC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (08) :2438-2442
[22]   Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line [J].
Nakano, K ;
Mizuno, T ;
Sowa, Y ;
Orita, T ;
Yoshino, T ;
Okuyama, Y ;
Fujita, T ;
OhtaniFujita, N ;
Matsukawa, Y ;
Tokino, T ;
Yamagishi, H ;
Oka, T ;
Nomura, H ;
Sakai, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (35) :22199-22206
[23]   Suppression of intestinal polyposis in Apc(Delta 716) knockout mice by inhibition of cyclooxygenase 2 (COX-2) [J].
Oshima, M ;
Dinchuk, JE ;
Kargman, SL ;
Oshima, H ;
Hancock, B ;
Kwong, E ;
Trzaskos, JM ;
Evans, JF ;
Taketo, MM .
CELL, 1996, 87 (05) :803-809
[24]   The suppression of 5-lipoxygenation of arachidonic acid in human polymorphonuclear leucocytes by the 15-lipoxygenase product (15S)-hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoic acid: Structure-activity relationship and mechanism of action [J].
Petrich, K ;
Ludwig, P ;
Kuhn, H ;
Schewe, T .
BIOCHEMICAL JOURNAL, 1996, 314 :911-916
[25]  
PINTO M, 1983, BIOL CELL, V47, P323
[26]   Interaction of 5-lipoxygenase with cellular proteins [J].
Provost, P ;
Samuelsson, B ;
Rådmark, O .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (05) :1881-1885
[27]  
RIGAS B, 1993, J LAB CLIN MED, V122, P518
[28]   Mediation of differentiating effects of butyrate on the intestinal cell line Caco-2 by transforming growth factor-β1 [J].
Schröder, O ;
Hess, S ;
Caspary, WF ;
Stein, J .
EUROPEAN JOURNAL OF NUTRITION, 1999, 38 (01) :45-50
[29]   TRANSFORMING GROWTH-FACTOR-BETA UP-REGULATES 5-LIPOXYGENASE ACTIVITY DURING MYELOID CELL MATURATION [J].
STEINHILBER, D ;
RADMARK, O ;
SAMUELSSON, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (13) :5984-5988
[30]   A HEAT-STABLE SERUM FACTOR UP-REGULATES 5-LIPOXYGENASE ACTIVITY IN HL-60 CELLS, MODULATION BY TNF-ALPHA OR GM-CSF [J].
STEINHILBER, D ;
RADMARK, O ;
SAMUELSSON, B .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 193 (03) :1083-1090